Literature DB >> 33333069

Modeling human embryo development with embryonic and extra-embryonic stem cells.

Bailey A T Weatherbee1, Tongtong Cui2, Magdalena Zernicka-Goetz3.   

Abstract

Early human post-implantation development involves extensive growth combined with a series of complex morphogenetic events. The lack of precise spatial and temporal control over these processes leads to pregnancy loss. Given the ethical and technical limitations in studying the natural human embryo, alternative approaches are needed to investigate mechanisms underlying this critical stage of human development. Here, we present an overview of the different stem cells and stem cell-derived models which serve as useful, albeit imperfect, tools in understanding human embryogenesis. Current models include stem cells that represent each of the three earliest lineages: human embryonic stem cells corresponding to the epiblast, hypoblast-like stem cells and trophoblast stem cells. We also review the use of human embryonic stem cells to model complex aspects of epiblast morphogenesis and differentiation. Additionally, we propose that the combination of both embryonic and extra-embryonic stem cells to form three-dimensional embryo models will provide valuable insights into cell-cell chemical and mechanical interactions that are essential for natural embryogenesis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33333069      PMCID: PMC8232073          DOI: 10.1016/j.ydbio.2020.12.010

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  112 in total

1.  Derivation of novel human ground state naive pluripotent stem cells.

Authors:  Ohad Gafni; Leehee Weinberger; Abed AlFatah Mansour; Yair S Manor; Elad Chomsky; Dalit Ben-Yosef; Yael Kalma; Sergey Viukov; Itay Maza; Asaf Zviran; Yoach Rais; Zohar Shipony; Zohar Mukamel; Vladislav Krupalnik; Mirie Zerbib; Shay Geula; Inbal Caspi; Dan Schneir; Tamar Shwartz; Shlomit Gilad; Daniela Amann-Zalcenstein; Sima Benjamin; Ido Amit; Amos Tanay; Rada Massarwa; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

2.  Comprehensive characterization of distinct states of human naive pluripotency generated by reprogramming.

Authors:  Xiaodong Liu; Christian M Nefzger; Fernando J Rossello; Joseph Chen; Anja S Knaupp; Jaber Firas; Ethan Ford; Jahnvi Pflueger; Jacob M Paynter; Hun S Chy; Carmel M O'Brien; Cheng Huang; Ketan Mishra; Margeaux Hodgson-Garms; Natasha Jansz; Sarah M Williams; Marnie E Blewitt; Susan K Nilsson; Ralf B Schittenhelm; Andrew L Laslett; Ryan Lister; Jose M Polo
Journal:  Nat Methods       Date:  2017-09-25       Impact factor: 28.547

3.  Contribution of human embryonic stem cells to mouse blastocysts.

Authors:  Daylon James; Scott A Noggle; Tomasz Swigut; Ali H Brivanlou
Journal:  Dev Biol       Date:  2006-07-01       Impact factor: 3.582

4.  Human trophectoderm cells are not yet committed.

Authors:  Caroline De Paepe; Greet Cauffman; An Verloes; Johan Sterckx; Paul Devroey; Herman Tournaye; Inge Liebaers; Hilde Van de Velde
Journal:  Hum Reprod       Date:  2012-12-19       Impact factor: 6.918

5.  Capacitation of human naïve pluripotent stem cells for multi-lineage differentiation.

Authors:  Maria Rostovskaya; Giuliano G Stirparo; Austin Smith
Journal:  Development       Date:  2019-04-03       Impact factor: 6.868

6.  Dissecting the dynamics of signaling events in the BMP, WNT, and NODAL cascade during self-organized fate patterning in human gastruloids.

Authors:  Sapna Chhabra; Lizhong Liu; Ryan Goh; Xiangyu Kong; Aryeh Warmflash
Journal:  PLoS Biol       Date:  2019-10-15       Impact factor: 8.029

Review 7.  Human Pre-gastrulation Development.

Authors:  Sissy E Wamaitha; Kathy K Niakan
Journal:  Curr Top Dev Biol       Date:  2018-02-13       Impact factor: 4.897

8.  Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche.

Authors:  Yue Shao; Kenichiro Taniguchi; Katherine Gurdziel; Ryan F Townshend; Xufeng Xue; Koh Meng Aw Yong; Jianming Sang; Jason R Spence; Deborah L Gumucio; Jianping Fu
Journal:  Nat Mater       Date:  2016-12-12       Impact factor: 43.841

9.  Epigenetic resetting of human pluripotency.

Authors:  Ge Guo; Ferdinand von Meyenn; Maria Rostovskaya; James Clarke; Sabine Dietmann; Duncan Baker; Anna Sahakyan; Samuel Myers; Paul Bertone; Wolf Reik; Kathrin Plath; Austin Smith
Journal:  Development       Date:  2017-08-01       Impact factor: 6.868

10.  Developmental potential of aneuploid human embryos cultured beyond implantation.

Authors:  Marta N Shahbazi; Tianren Wang; Xin Tao; Bailey A T Weatherbee; Li Sun; Yiping Zhan; Laura Keller; Gary D Smith; Antonio Pellicer; Richard T Scott; Emre Seli; Magdalena Zernicka-Goetz
Journal:  Nat Commun       Date:  2020-08-10       Impact factor: 14.919

View more
  6 in total

1.  Unifying synthetic embryology.

Authors:  Jake Cornwall-Scoones; Magdalena Zernicka-Goetz
Journal:  Dev Biol       Date:  2021-03-20       Impact factor: 3.582

Review 2.  Microfluidics for Neuronal Cell and Circuit Engineering.

Authors:  Rouhollah Habibey; Jesús Eduardo Rojo Arias; Johannes Striebel; Volker Busskamp
Journal:  Chem Rev       Date:  2022-09-07       Impact factor: 72.087

3.  Derivation of human triploid trophoblast stem cells.

Authors:  Xuhui Kong; Xin Chen; Songbang Ou; Wenjun Wang; Ruiqi Li
Journal:  J Assist Reprod Genet       Date:  2022-05       Impact factor: 3.357

4.  A framework for the responsible reform of the 14-day rule in human embryo research.

Authors:  Yaojin Peng; Jianwei Lv; Zhenyu Xiao; Lulu Ding; Qi Zhou
Journal:  Protein Cell       Date:  2022-02-15       Impact factor: 15.328

Review 5.  Human Embryo Models and Drug Discovery.

Authors:  Margit Rosner; Manuel Reithofer; Dieter Fink; Markus Hengstschläger
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

6.  Stem cells to reverse aging.

Authors:  Le Chang; Weiwen Fan; Xinghua Pan; Xiangqing Zhu
Journal:  Chin Med J (Engl)       Date:  2022-04-20       Impact factor: 6.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.